Literature DB >> 25036925

Predominant pathogen competition and core microbiota divergence in chronic airway infection.

Geraint B Rogers1, Christopher J van der Gast2, David J Serisier3.   

Abstract

Chronic bacterial lung infections associated with non-cystic fibrosis bronchiectasis represent a substantial and growing health-care burden. Where Pseudomonas aeruginosa is the numerically dominant species within these infections, prognosis is significantly worse. However, in many individuals, Haemophilus influenzae predominates, a scenario associated with less severe disease. The mechanisms that determine which pathogen is most abundant are not known. We hypothesised that the distribution of H. influenzae and P. aeruginosa would be consistent with strong interspecific competition effects. Further, we hypothesised that where P. aeruginosa is predominant, it is associated with a distinct 'accessory microbiota' that reflects a significant interaction between this pathogen and the wider bacterial community. To test these hypotheses, we analysed 16S rRNA gene pyrosequencing data generated previously from 60 adult bronchiectasis patients, whose airway microbiota was dominated by either P. aeruginosa or H. influenzae. The relative abundances of the two dominant species in their respective groups were not significantly different, and when present in the opposite pathogen group the two species were found to be in very low abundance, if at all. These findings are consistent with strong competition effects, moving towards competitive exclusion. Ordination analysis indicated that the distribution of the core microbiota associated with each pathogen, readjusted after removal of the dominant species, was significantly divergent (analysis of similarity (ANOSIM), R=0.07, P=0.019). Taken together, these findings suggest that both interspecific competition and also direct and/or indirect interactions between the predominant species and the wider bacterial community may contribute to the predominance of P. aeruginosa in a subset of bronchiectasis lung infections.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25036925      PMCID: PMC4274430          DOI: 10.1038/ismej.2014.124

Source DB:  PubMed          Journal:  ISME J        ISSN: 1751-7362            Impact factor:   10.302


  39 in total

1.  Long-term, low-dose erythromycin in bronchiectasis subjects with frequent infective exacerbations.

Authors:  D J Serisier; M L Martin
Journal:  Respir Med       Date:  2011-03-01       Impact factor: 3.415

2.  Lung function in bronchiectasis: the influence of Pseudomonas aeruginosa.

Authors:  S A Evans; S M Turner; B J Bosch; C C Hardy; M A Woodhead
Journal:  Eur Respir J       Date:  1996-08       Impact factor: 16.671

Review 3.  Anaerobic physiology of Pseudomonas aeruginosa in the cystic fibrosis lung.

Authors:  Max Schobert; Dieter Jahn
Journal:  Int J Med Microbiol       Date:  2010-10-16       Impact factor: 3.473

Review 4.  Pathogen-host interactions in Pseudomonas aeruginosa pneumonia.

Authors:  Ruxana T Sadikot; Timothy S Blackwell; John W Christman; Alice S Prince
Journal:  Am J Respir Crit Care Med       Date:  2005-02-01       Impact factor: 21.405

5.  Detection of anaerobic bacteria in high numbers in sputum from patients with cystic fibrosis.

Authors:  Michael M Tunney; Tyler R Field; Thomas F Moriarty; Sheila Patrick; Gerd Doering; Marianne S Muhlebach; Matthew C Wolfgang; Richard Boucher; Deirdre F Gilpin; Andrew McDowell; J Stuart Elborn
Journal:  Am J Respir Crit Care Med       Date:  2008-02-08       Impact factor: 21.405

6.  Role of bacteriocins in mediating interactions of bacterial isolates taken from cystic fibrosis patients.

Authors:  Suphan Bakkal; Sandra M Robinson; Claudia L Ordonez; David A Waltz; Margaret A Riley
Journal:  Microbiology (Reading)       Date:  2010-04-08       Impact factor: 2.777

7.  Partitioning core and satellite taxa from within cystic fibrosis lung bacterial communities.

Authors:  Christopher J van der Gast; Alan W Walker; Franziska A Stressmann; Geraint B Rogers; Paul Scott; Thomas W Daniels; Mary P Carroll; Julian Parkhill; Kenneth D Bruce
Journal:  ISME J       Date:  2010-12-09       Impact factor: 10.302

8.  A relationship between Pseudomonal growth behaviour and cystic fibrosis patient lung function identified in a metabolomic investigation.

Authors:  Justyna Kozlowska; Damian W Rivett; Louic S Vermeer; Mary P Carroll; Kenneth D Bruce; A James Mason; Geraint B Rogers
Journal:  Metabolomics       Date:  2013-12       Impact factor: 4.290

Review 9.  Interspecies interaction between Pseudomonas aeruginosa and other microorganisms.

Authors:  Yosuke Tashiro; Yutaka Yawata; Masanori Toyofuku; Hiroo Uchiyama; Nobuhiko Nomura
Journal:  Microbes Environ       Date:  2013-01-30       Impact factor: 2.912

10.  Inhaled, dual release liposomal ciprofloxacin in non-cystic fibrosis bronchiectasis (ORBIT-2): a randomised, double-blind, placebo-controlled trial.

Authors:  David J Serisier; Diana Bilton; Anthony De Soyza; Philip J Thompson; John Kolbe; Hugh W Greville; David Cipolla; Paul Bruinenberg; Igor Gonda
Journal:  Thorax       Date:  2013-05-16       Impact factor: 9.139

View more
  15 in total

1.  Sputum purulence-associated microbial community compositions in adults with bronchiectasis.

Authors:  Wei-Jie Guan; Yan Huang; Chun-Lan Chen; Jing-Jing Yuan; Hui-Min Li; Yong-Hua Gao; Rong-Chang Chen; Nan-Shan Zhong
Journal:  J Thorac Dis       Date:  2018-09       Impact factor: 2.895

2.  Landscape Seroprevalence of Three Hemorrhagic Disease-Causing Viruses in a Wild Cervid.

Authors:  Emma Tomaszewski; Megan Jennings; Brandon Munk; Randy Botta; Rebecca Lewison
Journal:  Ecohealth       Date:  2021-09-13       Impact factor: 3.184

3.  Lower Airway Bacterial Colonization Patterns and Species-Specific Interactions in Chronic Obstructive Pulmonary Disease.

Authors:  David M Jacobs; Heather M Ochs-Balcom; Jiwei Zhao; Timothy F Murphy; Sanjay Sethi
Journal:  J Clin Microbiol       Date:  2018-09-25       Impact factor: 5.948

Review 4.  Lower airway colonization and inflammatory response in COPD: a focus on Haemophilus influenzae.

Authors:  Lydia J Finney; Andrew Ritchie; Elizabeth Pollard; Sebastian L Johnston; Patrick Mallia
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2014-10-13

5.  The impact of persistent bacterial bronchitis on the pulmonary microbiome of children.

Authors:  Leah Cuthbertson; Vanessa Craven; Lynne Bingle; William O C M Cookson; Mark L Everard; Miriam F Moffatt
Journal:  PLoS One       Date:  2017-12-27       Impact factor: 3.240

Review 6.  Geographic variation in the aetiology, epidemiology and microbiology of bronchiectasis.

Authors:  Ravishankar Chandrasekaran; Micheál Mac Aogáin; James D Chalmers; Stuart J Elborn; Sanjay H Chotirmall
Journal:  BMC Pulm Med       Date:  2018-05-22       Impact factor: 3.317

Review 7.  Pathogenesis, imaging and clinical characteristics of CF and non-CF bronchiectasis.

Authors:  Jürgen Schäfer; Matthias Griese; Ravishankar Chandrasekaran; Sanjay H Chotirmall; Dominik Hartl
Journal:  BMC Pulm Med       Date:  2018-05-22       Impact factor: 3.317

8.  Insights into the respiratory tract microbiota of patients with cystic fibrosis during early Pseudomonas aeruginosa colonization.

Authors:  Marlène Keravec; Jérôme Mounier; Emmanuel Prestat; Sophie Vallet; Janet K Jansson; Gaëtan Burgaud; Sylvain Rosec; Stéphanie Gouriou; Gilles Rault; Emmanuel Coton; Georges Barbier; Geneviève Héry-Arnaud
Journal:  Springerplus       Date:  2015-08-09

9.  Bacterial community structure transformed after thermophilically composting human waste in Haiti.

Authors:  Yvette M Piceno; Gabrielle Pecora-Black; Sasha Kramer; Monika Roy; Francine C Reid; Eric A Dubinsky; Gary L Andersen
Journal:  PLoS One       Date:  2017-06-01       Impact factor: 3.240

10.  Altered community compositions of Proteobacteria in adults with bronchiectasis.

Authors:  Wei-Jie Guan; Jing-Jing Yuan; Hui-Min Li; Yong-Hua Gao; Chun-Lan Chen; Yan Huang; Rong-Chang Chen; Nan-Shan Zhong
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2018-07-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.